2m 2m 2m 2m 2m 2m 2m
SKYE BIOSCIENCE (SKYE)
NASDAQ
$0.76-$0.01 (-1.31%)
Price as of Jun 03, 2026 7:47 PM EDT- $27.3MMarket Cap
- -68.83%1-Year Change
- BiotechnologyIndustry
SKYE BIOSCIENCE (SKYE)
$0.76-$0.01 (-1.31%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -42.4M +126.51% | -18.7M +221.36% | -5.8M -3.20% | -6.0M +105.08% | |
Depreciation and Amortization Expense | 723,352 +142.22% | 298,640 +140.35% | 124,251 +8.05% | 114,998 +236.93% | |
Total Operating Expenses | 58.2M +92.64% | 30.2M -13.08% | 34.7M +89.69% | 18.3M +133.34% | |
Operating Profit | -58.2M +92.64% | -30.2M -13.08% | -34.7M +89.69% | -18.3M +133.34% | |
Interest Income | 1.9M -37.80% | 3.0M +2,929.55% | 99,974 +425.87% | 19,011 +633,600.00% | |
Interest Expense | 0 +100.00% | -749,308 -17.32% | -906,270 +36.25% | -665,133 -13.52% | |
Interest Income and Expense and Net | 1.9M -17.35% | 2.3M +382.71% | -806,296 +24.79% | -646,122 -16.00% | |
Total Nonoperating Income and Expense | 2.2M -38.27% | 3.6M +225.11% | -2.9M +149.84% | -1.2M +72.99% | |
Income before Taxes | -55.9M +110.56% | -26.6M -29.45% | -37.6M +93.28% | -19.5M +128.58% | |
Income Taxes | 5,400 -46.38% | 10,071 +179.75% | 3,600 -46.60% | 6,741 +221.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -55.9M +110.50% | -26.6M -29.43% | -37.6M +93.23% | -19.5M +128.60% | |
Net Income from Continuing Operations Applicable to Common | -55.9M +110.56% | -26.6M -29.45% | -37.6M +93.28% | -19.5M +128.58% | |
Basic EPS and Net Income | -1.41 +93.15% | -0.73 -86.41% | -5.37 +13,325.00% | -0.04 +100.00% | |
Diluted EPS and Net Income | -1.41 +93.15% | -0.73 -86.41% | -5.37 +13,325.00% | -0.04 +100.00% | |
Basic Weighted Average Shares | 39.7M +8.70% | 36.5M +420.79% | 7.0M -98.74% | 555.3M +36.56% | |
Diluted Weighted Average Shares | 39.7M +8.70% | 36.5M +420.79% | 7.0M -98.74% | 555.3M +36.56% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.9M -91.40% | 68.4M +5,345.15% | 1.3M +0.96% | 1.2M -86.15% | |
Short-Term Investments | 19.9M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 25.7M -62.38% | 68.4M +5,345.15% | 1.3M +0.96% | 1.2M -86.15% | |
Total Current Assets | 27.1M -61.75% | 70.8M +507.92% | 11.7M +30.27% | 8.9M -6.95% | |
Accumulated Depreciation | 773,647 +231.31% | 233,513 N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 898,930 -37.26% | 1.4M +3,210.73% | 43,276 -50.74% | 87,854 +0.16% | |
Total Long-Term Assets | 53,910 0.00% | 53,910 +548.81% | 8,309 0.00% | 8,309 0.00% | |
Total Assets | 28.3M -61.09% | 72.8M +509.39% | 11.9M +31.05% | 9.1M -7.55% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 0 -100.00% | 4.4M +136.53% | 1.8M -6.41% | |
Total Current Liabilities | 8.2M +89.11% | 4.3M -68.79% | 13.9M +14.70% | 12.1M +209.78% | |
Total Long-Term Debt | N/A N/A | 4.4M 0.00% | 4.4M +136.53% | 1.8M N/A | |
Total Long-Term Liabilities | 83,999 -69.25% | 273,162 +59.53% | 171,230 N/A | 0 -100.00% | |
Total Liabilities | 8.3M +79.73% | 4.6M -67.23% | 14.1M +16.12% | 12.1M +203.67% | |
Retained Earnings | -186.9M +42.71% | -130.9M +25.45% | -104.4M +56.41% | -66.7M +41.23% | |
Total Stockholders Equity | 20.0M -70.62% | 68.2M +3,296.88% | -2.1M -29.13% | -3.0M -151.30% | |
Total Shares Outstanding | 33.4M +7.76% | 31.0M +150.82% | 12.3M -98.65% | 913.5M +91.87% | |
Cash Flow | |||||
Cash from Operating Activities | -43.1M +70.63% | -25.2M +80.89% | -14.0M +9.48% | -12.7M +96.82% | |
Capital Expenditures | 6,312 -99.61% | 1.6M +12,681.09% | 12,550 -55.27% | 28,060 -69.12% | |
Cash from Investing Activities | -19.5M +7,839.37% | -245,615 -103.72% | 6.6M +26.50% | 5.2M +5,838.55% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 29,571 -99.96% | 83.6M +408.18% | 16.4M +7,975.36% | -208,794 -101.60% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -110.66% +76.40% | -62.73% -82.46% | -357.64% +74.09% | -205.44% +50.99% | |
Return on Equity | -126.85% +57.61% | -80.48% -105.49% | 1,464.81% +207.37% | -1,364.20% +405.44% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 3.30 -79.77% | 16.32 +1,847.72% | 0.84 +13.56% | 0.74 -69.96% | |
Cash Ratio | 0.72 -95.45% | 15.77 +17,342.48% | 0.09 -11.98% | 0.10 -95.53% | |
Debt-to-Equity Ratio | N/A N/A | 0.06 +101.57% | -4.10 +233.74% | -1.23 -464.90% | |
Debt-to-Assets Ratio | N/A N/A | 0.06 -91.79% | 0.73 +80.50% | 0.41 +102.45% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow